CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
AMYPAD aims to clarify the role of beta-amyloid imaging in diagnosing Alzheimer’s disease by studying its dynamics across a large cohort. The project seeks to improve diagnostic accuracy and treatment strategies through extensive imaging data collection and analysis.
Beta-amyloid (β-amyloid) deposition is considered to be a necessary - but not sufficient - step on the path towards Alzheimer’s disease (AD).
Depiction of brain β-amyloid in vivo can support an early diagnosis, and even provide an opportunity for consider secondary prevention of AD.
Currently, however, the value of β-amyloid PET remains elusive, reason why this procedure is typically not reimbursed.Understanding the value of imaging of β-amyloid using positron emission tomography (PET) provides…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, Edinburgh
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
FUNDACIO BARCELONABETA BRAIN RESEARCH CENTER
Spain, Barcelona
Type: Research institute
Activity type: Research Organisations
SME: No
Switzerland, Geneve
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Sweden, Stockholm
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
